Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BVMF/Z1BH34 stock hub

BVMF/Z1BH34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/Z1BH34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
78B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/Z1BH34
In the news

Latest news · BVMF/Z1BH34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.7
P25 11.3P50 14.6P75 19.6
Trailing P/E19.6
P25 15.2P50 21.5P75 27.3
ROE6.1
P25 5.3P50 12.3P75 22.5
ROIC6.2
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/Z1BH34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
218
Groups with data
11
Currency
USD
Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
17,000
Employees Change
-1,000%
Employees Change Percent
-5.56
Enterprise value
BRL 112.9B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical Devices
Last refreshed
2026-05-10
Market cap
BRL 78B
Price
BRL 120
Price currency
BRL
Rev Per Employee
2,580,468.36x
Sector
Healthcare
Sic
3842
Symbol
bvmf/Z1BH34
Website
https://www.zimmerbiomet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
5.09%
EV Earnings
28.42x
EV/EBIT
15.66x
EV/EBITDA
8.71x
EV/FCF
18.99x
EV/Sales
2.74x
FCF yield
7.62%
Forward P/E
9.69x
P/B ratio
1.18x
P/E ratio
19.64x
P/S ratio
1.78x
PE Ratio10 Y
64.65x
PE Ratio3 Y
28.98x
PE Ratio5 Y
48.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
17.5%
EBITDA Margin
30.69%
FCF margin
13.55%
Gross margin
70.18%
Gross Profit
BRL 30.8B
Gross Profit Growth
7.66%
Gross Profit Growth Q
12.01%
Gross Profit Growth3 Y
5.07%
Gross Profit Growth5 Y
4.14%
Net Income
BRL 4B
Net Income Growth
-16.66%
Net Income Growth Q
30.82%
Net Income Growth3 Y
19.18%
Net Income Growth5 Y
6.04%
Pretax Margin
10.74%
Profit Margin
9.05%
Profit Per Employee
BRL 233,587
ROA
4.1
Roa5y
3.96
ROCE
7.41
ROE
6.06
Roe5y
5.43
ROIC
6.24
Roic5y
6.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr1y
-23.03%
Cagr3y
-10.35%
Cagr5y
-11.28%
Div CAGR3
1.12%
Div CAGR5
-0.44%
EPS Growth
-14.45
EPS Growth Q
34.07
EPS Growth3 Y
21.69
EPS Growth5 Y
7.16
FCF Growth
-8.32%
FCF Growth Q
-11.71%
FCF Growth3 Y
9.32%
FCF Growth5 Y
12.99%
OCF Growth
1.18%
OCF Growth Q
-6.11%
OCF Growth10 Y
4.96%
OCF Growth3 Y
7.29%
OCF Growth5 Y
10.85%
Revenue Growth
9.23x
Revenue Growth Q
9.3x
Revenue Growth3 Y
5.76x
Revenue Growth5 Y
4.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.37
Assets
BRL 118.5B
Cash
BRL 2.5B
Current Assets
BRL 24.4B
Current Liabilities
BRL 14.1B
Debt
BRL 39.6B
Debt EBITDA
BRL 2.87
Debt Equity
BRL 0.6
Debt FCF
BRL 6.66
Equity
BRL 66.2B
Interest Coverage
4.98
Liabilities
BRL 52.4B
Long Term Assets
BRL 94.1B
Long Term Liabilities
BRL 38.3B
Net Cash
BRL -37.1B
Net Cash By Market Cap
BRL -47.54
Net Debt EBITDA
BRL 2.75
Net Debt Equity
BRL 0.56
Net Debt FCF
BRL 6.24
Tangible Book Value
BRL -9.4B
Tangible Book Value Per Share
BRL -48.72
WACC
5.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.73
Inventory Turnover
1.12
Net Working Capital
BRL 14.6B
Quick ratio
0.77
Working Capital
BRL 10.9B
Working Capital Turnover
BRL 16.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
2.25%
Dividend Growth
-8.14%
Dividend Growth Years
0%
Dividend per share
BRL 0.86
Dividend Years
7
Dividend Yield
0.71%
Ex Div Date
2026-03-30
Last Dividend
BRL 0.2
Payout Frequency
Quarterly
Payout Ratio
24.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
-23.01%
3Y total return
-27.94%
50-day SMA
153.1
5Y total return
-45.04%
All Time High
231.4
All Time High Change
-48.19%
All Time High Date
2021-03-01
All Time Low
100
All Time Low Change
19.88%
All Time Low Date
2020-03-19
ATR
5.22
Beta
0.47
Ch YTD
-3.29
High
119.9
High52
132
High52 Date
2025-05-21
High52ch
-9.21%
Low
119.9
Low52
115
Low52 Date
2025-11-06
Low52ch
4.24%
Ma50ch
-21.67%
RSI
37.56
RSI Monthly
37.39
RSI Weekly
43.45
Sharpe ratio
0.06x
Sortino ratio
0.19
Total Return
2.96%
Tr YTD
-2.95
Tr1m
3.22%
Tr1w
3.35%
Tr3m
-2.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 7.7B
Operating Income Growth
-4.58
Operating Income Growth Q
20.54
Operating Income Growth3 Y
2.05
Operating Income Growth5 Y
9.53
Operating margin
17.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
192,868,690%
Net Borrowing
707,644,800
Shares Insiders
0.18%
Shares Institutions
104.74%
Shares Qo Q
-1.16%
Shares Yo Y
-2.25%
Short Ratio
4.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
BRL 5.4B
Average Volume
51x
Bv Per Share
341.8
CAPEX
BRL -2.8B
Ch1m
3.03
Ch1w
3.35
Ch1y
-23.55
Ch3m
-3.29
Ch3y
-29.31
Ch5y
-46.57
Ch6m
-7.13
Change
1.42%
Change From Open
0
Close
118.2
Days Gap
1.42
Depreciation Amortization
5,451,813,480
Dollar Volume
119.9
Earnings Date
2026-04-28
EBIT
BRL 7.7B
EBITDA
BRL 13.5B
EPS
BRL 20.12
F Score
6
FCF
BRL 5.9B
FCF EV Yield
5.27x
Financing CF
-3,227,066,085
Fiscal Year End
December
Founded
1,927
Goodwill
48,806,851,560
Graham Number
118.14965
Graham Upside
-1.44
Income Tax
BRL 741.8M
Investing CF
-10,583,170,008
Is Primary Listing
0
Last Earnings Date
2026-04-28
Last Report Date
2026-03-31
Lynch Fair Value
BRL 36.87
Lynch Upside
-69.25
Ma20
133.2
Ma20ch
-9.97%
Net CF
-5,009,621,018
Open
119.9
P FCF Ratio
13.12
P OCF Ratio
8.93
Payment Date
2026-05-07
Ppne
10,868,736,140
Price Date
2026-04-14
Price EBITDA
BRL 5.79
Relative Volume
0.02x
Revenue
43,867,962,198x
SBC By Revenue
1.13x
Share Based Comp
494,545,530
Tax By Revenue
1.69x
Tax Rate
15.75%
Tr6m
-6.49%
Volume
1
Z Score
2.55
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BVMF/Z1BH34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.7%
$0.86 annual per share
Payout ratio
+24.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-0.4%
0 consecutive years of growth
Total shareholder yield
+3.0%
Next ex-dividend date: 2026-03-30
Performance

BVMF/Z1BH34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-23.0%
S&P 500 1Y: n/a
3Y total return
-27.9%
S&P 500 3Y: n/a
5Y total return
-45.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/Z1BH34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+104.7%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.4 days to cover
Y/Y dilution
-2.2%
Negative means the company is buying back shares.
Technical

BVMF/Z1BH34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
37.6
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
0.47
Less volatile than the market
Sharpe ratio
0.06
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/Z1BH34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/Z1BH34 stock rating?

bvmf/Z1BH34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/Z1BH34 analysis?

The full report lives at /stocks/bvmf/Z1BH34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/Z1BH34?

The latest report frames bvmf/Z1BH34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/Z1BH34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bvmf/Z1BH34 stock profile: metrics, valuation and analysis | Agent IA du Marché Boursier